Should You Buy Kanzhun Ltd (BZ) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Buy
Latest Price
18.900
1 Day change
0.37%
52 Week Range
25.260
Analysis Updated At
2026/01/28
BUY for a long-term beginner right now. Despite a still-bearish moving-average setup, BZ is trading near support with improving momentum (MACD turning up) while fundamentals (Q3 2025 growth and profitability) and options positioning both skew bullish. With ~$50k–$100k to invest and little patience for waiting on a perfect entry, this is a reasonable time to start/establish a long-term position rather than sit out.
Technical Analysis
Price/Trend: The broader trend is still bearish (SMA_200 > SMA_20 > SMA_5), meaning the stock has been in a longer-term downtrend and has not fully reversed yet. Momentum: MACD histogram is slightly positive and expanding (0.00632), suggesting downside momentum is fading and an early stabilization/turn is forming. RSI(6)=38.0 is weak but not deeply oversold; it supports a “near-support, improving momentum” setup rather than a strong breakdown. Levels: Pivot 19.193 is just above the current price (19.05). Immediate support is S1=18.713 (then S2=18.416). Near-term resistance is R1=19.673 and R2=19.97. Practical read: This is a buyable zone for long-term investors because price is close to defined support, while early momentum is improving—though a clean trend reversal would be more convincing if it reclaims and holds above ~19.67–19.97.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment/Positioning: Put-call ratios are very low on both open interest (0.22) and volume (0.12), indicating call-heavy positioning and generally bullish sentiment. Activity: Today’s option volume vs 30-day average is elevated (~155%), suggesting rising attention/positioning. Volatility: IV percentile (~17) and IV rank (~16) are low, implying options are relatively cheap versus recent history; that typically aligns with calmer sentiment and can indicate the market isn’t pricing in major downside shock right now.
Technical Summary
Sell
9
Buy
0
Positive Catalysts
with accelerating profitability: revenue +13.17% YoY, net income +72.22% YoY, EPS +63.46% YoY, and gross margin improved to 85.77%. Options market positioning is notably bullish (very low put/call ratios) with increased activity. Analyst price targets cited ($25–$
imply meaningful upside from ~$19.05 if execution continues.
Neutral/Negative Catalysts
Technical backdrop remains bearish on moving averages (trend not fully reversed), so the stock can still chop or retest support (18.71/18.42). No fresh news catalysts in the last week to force an immediate re-rating. Analyst coverage includes at least one Hold initiation, indicating not all Street views are uniformly bullish.
Financial Performance
Latest quarter: 2025/Q3. Revenue rose to 2,163,281,000 (+13.17% YoY). Net income increased to 806,633,000 (+72.22% YoY). EPS grew to 0.85 (+63.46% YoY). Gross margin improved to 85.77% (+2.63% YoY). Overall: solid top-line growth with much faster earnings growth and expanding margin—an attractive long-term profile.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent Street trend is mixed but leans constructive on upside: Barclays reiterated Overweight and raised its price target to $28 from $25 (seeing demand trends turning up). 86 Research initiated at Hold with a $25 target. Net effect: targets cluster well above the current ~$19 level, suggesting pros see upside, but the presence of a Hold initiation implies some skepticism about timing/valuation or near-term execution. Wall Street pros (bull case): improving demand, strong earnings leverage, high margins. Cons (bear case): not universally rated Buy/Overweight; technical trend still recovering.
Influential/politician trading: No recent congress trading data available in the last 90 days (no signal from that channel).
Wall Street analysts forecast BZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BZ is 26.17 USD with a low forecast of 25 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast BZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BZ is 26.17 USD with a low forecast of 25 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 18.830
Low
25
Averages
26.17
High
28
Current: 18.830
Low
25
Averages
26.17
High
28
Morgan Stanley
Morgan Stanley
Overweight -> Equal Weight
downgrade
AI Analysis
2025-12-10
Reason
Morgan Stanley
Morgan Stanley
Price Target
AI Analysis
2025-12-10
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded Buzzi to Equal Weight from Overweight with a price target of EUR 55, up from EUR 53. The firm adjusted ratings in the European budling and construction group as part of a 2026 outlook.
Barclays
Overweight
maintain
$25 -> $28
2025-11-19
Reason
Barclays
Price Target
$25 -> $28
2025-11-19
maintain
Overweight
Reason
Barclays raised the firm's price target on Kanzhun to $28 from $25 and keeps an Overweight rating on the shares. While the company's Q3 results were in line, its underling demand trends "are clearly turning up," the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BZ
